Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Allergan plc (AGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/14/2020 8-K Quarterly results
05/08/2020 8-K Quarterly results
05/06/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Announcement relating to the outcome of the Court Sanction Hearing"
04/21/2020 8-K Temporary Suspension of Trading Under Registrant's Employee Benefit Plans, Other Events, Financial Statements and Exhibits ...
Docs: "FORM 8-K",
"Blackout Notice, provided to directors and Section 16 officers of Allergan"
03/03/2020 8-K Quarterly results
02/10/2020 8-K Quarterly results
01/27/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep"
11/05/2019 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Investor FAQ"
11/05/2019 8-K Quarterly results
10/15/2019 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits  Interac...
Docs: "FORM 8-K",
"Allergan Shareholders Approve Proposed Acquisition by AbbVie"
09/27/2019 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "FORM 8-K",
"Allergan and AbbVie Receive Second Request from Federal Trade Commission on Pending Transaction DUBLIN, IRELAND - SEPTEMBER 27, 2019 -"
09/16/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "FORM 8-K",
"PricewaterhouseCoopers Ireland Report",
"J.P. Morgan Report"
09/10/2019 8-K Quarterly results
08/06/2019 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Investor FAQ",
"Investor FAQ"
08/06/2019 8-K Quarterly results
06/25/2019 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Transaction Agreement, by and among AbbVie, Inc., Venice Subsidiary, LLC and Allergan plc",
"Appendix III to the Rule 2.5 Announcement, (Conditions Appendix)",
"Expenses Reimbursement Agreement, by and between Allergan plc and AbbVie, Inc",
"Rule 2.5 Announcement",
"Agreement Frequently Asked Questions",
"Employee Letter from Brenton L. Saunders",
"Employee Townhall Presentation",
"Customer Letter - Generic",
"Customer Letter - Medical Aesthetics",
"Customer Letter - Eye Care"
05/07/2019 8-K Quarterly results
05/01/2019 8-K Submission of Matters to a Vote of Security Holders
Docs: "FORM 8-K"
03/22/2019 8-K Other Events
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report : March 22, 2019 ALLERGAN PLC Ireland 001-36867 98-1114402 Clonshaugh Business and Technology Park Coolock, Dublin, D17 E400, Ireland 261-7000"
02/28/2019 8-K Quarterly results
02/19/2019 8-K Quarterly results
02/08/2019 8-K Quarterly results
01/29/2019 8-K Quarterly results
01/25/2019 8-K Other Events
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report : January 25, 2019 ALLERGAN PLC Ireland 001-36867 98-1114402 Clonshaugh Business and Technology Park Coolock, Dublin, D17 E400, Ireland 261-7000"
11/15/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "FORM 8-K",
"Fourth Supplemental Indenture dated November 15, 2018, among Allergan Funding SCS and Warner Chilcott Limited, Allergan Capital S.à r.l. and Allergan Finance, LLC, as guarantors, and Wells Fargo Bank, National Association, as trustee",
"Opinion of Cleary Gottlieb Steen & Hamilton LLP",
"Opinion of Loyens & Loeff Luxembourg S.à r.l",
"Opinion of Appelby (Bermuda) Limited",
"Opinion of Greenberg Traurig, LLP"
11/13/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Underwriting Agreement, by and among Allergan Funding SCS, the guarantors listed therein, Allergan plc, and Barclays Bank PLC, Goldman Sachs & Co. LLC, J.P. Morgan Securities plc, and Morgan Stanley & Co. International plc, as representatives of the several underwriters listed in Schedule 1 thereto"
10/31/2018 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Investor FAQ",
"Investor FAQ"
10/30/2018 8-K Quarterly results
08/29/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FORM 8-K"
08/08/2018 8-K Appointed a new director
Docs: "FORM 8-K"
07/26/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
06/14/2018 8-K Appointed a new director
Docs: "FORM 8-K"
05/03/2018 8-K Submission of Matters to a Vote of Security Holders
Docs: "FORM 8-K"
04/30/2018 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy